Fatigue Levels Vary for Patients With Psoriatic Disease

Share this content:
Fatigue Levels Vary for Patients With Psoriatic Disease
Fatigue Levels Vary for Patients With Psoriatic Disease

FRIDAY, Dec. 30, 2016 (HealthDay News) -- Patients with psoriatic arthritis have higher levels of fatigue than patients with psoriasis treated with phototherapy or systemic treatment, according to a research letter published online Dec. 22 in the British Journal of Dermatology.

Anne-Marie Tobin, M.B.B.Ch., from Adelaide and Meath Hospital Incorporating National Children's Hospital in Dublin, and colleagues conducted a prospective observational study to examine levels of fatigue among 103 patients with psoriasis prior to commencing phototherapy, 97 with psoriasis attending the systemic clinic, and 100 diagnosed with psoriatic arthritis by a rheumatologist.

The researchers found that the mean fatigue scores, measured using a visual analogue scale (VAS), were relatively low in all groups: 2.0, 3.4, and 3.9 for the phototherapy, systemic treatment, and psoriatic arthritis groups, respectively. Severe fatigue occurred in 11, 21, and 31 percent of phototherapy patients, systemic clinic attendees, and patients with psoriatic arthritis. Higher levels of fatigue were seen for patients with psoriatic arthritis versus those with psoriasis receiving phototherapy or systemic treatment (P = 0.009). Across all groups, female patients reported higher levels of fatigue than male patients (P = 0.0001). Fatigue scores were correlated with depression scores, but not with anxiety scores, in the Hospital Anxiety and Depression Scales.

"The VAS-Fatigue may be a predictor of depression in female patients or incipient joint involvement in patients with psoriasis and is a simple tool to implement in clinical practice," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Keytruda for All Cancers With Genetic Biomarker

FDA Approves Keytruda for All Cancers With Genetic ...

First medication sanctioned for any cancer, regardless of origin

Regular Chocolate Consumption May Lower Risk of A-Fib

Regular Chocolate Consumption May Lower Risk of A-Fib

13-year study finds lower odds for atrial fibrillation in people eating moderate amounts

Doctors Urged to Check Patient Drug History Before Opioid Rx

Doctors Urged to Check Patient Drug History Before ...

Opioid abuse down when physicians are legally obligated to check patient's drug history

is free, fast, and customized just for you!

Already a member?

Sign In Now »